Pharming Group N.V. Interest Paid Classified As Financing Activities
Pharming Group N.V. (PHAR) reported Interest Paid Classified As Financing Activities of $5.07 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:InterestPaidClassifiedAsFinancingActivities · last filed 2026-04-02
EUR
| Period end | Interest Paid Classified As Financing Activities 12 month |
|---|---|
| 2020-12-31 | 1.88M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 8.42M EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | 11.06M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Interest Paid Classified As Financing Activities 12 month |
|---|---|
| 2025-12-31 | $5.07M 20-F · filed 2026-04-02 |
| 2024-12-31 | $4.46M 20-F · filed 2026-04-02 |
| 2023-12-31 | $4.05M 20-F · filed 2026-04-02 |
| 2022-12-31 | $3.95M 20-F · filed 2025-04-03 |
| 2021-12-31 | $4.45M 20-F · filed 2024-04-04 |
| 2020-12-31 | $2.14M 20-F · filed 2023-04-05 |
| 2019-12-31 | $9.43M 20-F · filed 2022-04-06 |